drug pricing

What's Up Next? Biotech And Pharma Predictions For 2016
Forbes
Fri, 01/1/16 - 01:04 pm
biotech
Martin Shkreli
Valeant Pharmaceuticals
drug pricing
Theranos
Obamacare
Pfizer
CRISPR-Cas9
What Happened in Biotech in 2015?
Motley Fool
Tue, 12/29/15 - 09:30 am
biotech
Turing Pharmaceuticals
Valeant Pharmaceuticals
Gilead Sciences
drug pricing
M&A
Celgene
Receptos
drug approvals
The Worst Johnson & Johnson Headlines in 2015
Motley Fool
Mon, 12/28/15 - 04:32 pm
JNJ
drug pricing
Olysio
Why drug pricing will continue to loom large for pharma in 2016
Stat
Mon, 12/28/15 - 10:14 am
drug pricing
The top biopharma trends for 2016
Fierce Biotech
Sun, 12/27/15 - 10:32 am
IPOs
M&A
venture capital
drug pricing
globalization
Brace yourselves: The drug pricing brouhaha isn't dying down
Fierce Pharma
Sat, 12/26/15 - 08:45 pm
drug pricing
Martin Shkreli
Pricing pressure: Doubling down on the political drama
Fierce Biotech
Sat, 12/26/15 - 12:07 pm
Martin Shkreli
drug pricing
Pharma, Heal Thyself On Drug Pricing
Forbes
Sat, 12/26/15 - 12:06 pm
drug pricing
The year's top pharma marketing controversies
Medical Marketing and Media
Wed, 12/23/15 - 09:50 pm
FDA
drug pricing
Amarin
social media
PBMs
AstraZeneca
Pfizer
Valeant Pharmaceuticals
drug ads
Afrezza
Novartis CEO: Pharma needs to share both pain and gain with payers, providers
BioPharma Dive
Mon, 12/21/15 - 11:02 am
Novartis
Pharma CEOs
Joe Jimenez
drug pricing
payers
Defiant Shkreli hits back at feds, says arrest was driven by his price hikes
BioPharma Dive
Mon, 12/21/15 - 10:43 am
Martin Shkreli
securities fraud
drug pricing
Sovaldi is expensive, but this drug cost N.C. Medicaid even more
Bizjournals.com
Wed, 12/16/15 - 10:55 am
Sovaldi
Gilead Sciences
drug pricing
North Carolina
Medicaid
Otsuka
Abilify
Why Martin Shkreli's Price Hike May Hurt Everyone...Including You And The Pharmaceutical Industry
Forbes
Wed, 12/16/15 - 10:02 am
Martin Shkreli
drug pricing
Lilly's price for Portrazza way too high for its limited benefit in lung cancer, doctors say
Fierce Pharma
Mon, 12/14/15 - 04:15 pm
drug pricing
Portrazza
Eli Lilly
non-small cell lung cancer
Senators mull speedier generics pathway amid outrage over Turing, Valeant price hikes
BioPharma Dive
Thu, 12/10/15 - 11:09 am
Senate
generics
drug pricing
Mylan slapped with Justice Department subpoena over doxycycline pricing
BioPharma Dive
Mon, 12/7/15 - 12:08 pm
Mylan Labs
doxycycline
antibiotics
drug pricing
For Hepatitis C Drugs, U.S. Prices Are Cheaper Than In Europe
Forbes
Fri, 12/4/15 - 08:13 pm
hepatitis C
Europe
drug pricing
Martin Shkreli Admits He Messed Up: He Should've Raised Prices Even Higher
Forbes
Thu, 12/3/15 - 09:52 pm
Martin Shkreli
Daraprim
drug pricing
Why drug companies need to go from reactive to proactive on pricing
Medical Marketing and Media
Thu, 12/3/15 - 09:44 pm
drug pricing
Gilead Sciences, Inc: Can the Senate Report Trigger Policy Changes?
Bidness, ETC
Thu, 12/3/15 - 09:35 am
Gilead Sciences
drug pricing
Senate
hepatitis C

Pages